Organon (OGN) Net Margin (2020 - 2026)
Organon (OGN) posted quarterly Net Margin of 6.93% for Q2 2026, down 216.0% year-over-year from 5.98% in Q2 2025, and down 30.68% on a QoQ basis from 10.0% in Q1 2026.
Organon (OGN) Net Margin (2020 - 2026) Analysis & Trends
Organon has reported Net Margin for 6 years, with the latest figure at 6.93% in Q2 2026.
- Net Margin for Q2 2026 came in at 6.93%, down 216.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 3.41% (down 773.0% YoY), and the FY2025 annual result was 3.01%, down 1049.0% from the prior year.
- Net Margin fell to 6.93% in Q2 2026, from 10.0% in the prior quarter.
- Over five years, Net Margin peaked at 34.17% in Q4 2023 and troughed at 13.6% in Q4 2025.
- A 4-year average of 10.48% and a median of 9.99% in 2025 frame the typical range for Net Margin.
- The largest YoY upside for Net Margin was 1887 bps in 2024 against a maximum downside of 2732 bps in 2024.
- A 4-year view of Net Margin shows it stood at 34.17% in 2023, then slumped by 80 bps to 6.85% in 2024, then slumped by 299 bps to 13.6% in 2025, then soared by 151 bps to 6.93% in 2026.
- Per Business Quant data, the three most recent Net Margin figures were 6.93% in Q2 2026, 10.0% in Q1 2026, and 13.6% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 21.28% |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -8.05% |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 22.65% |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 16.30% |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -1.58% |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 5.17% |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | 6.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.93% |
| Mar 31, 2026 | 10.00% |
| Dec 31, 2025 | -13.60% |
| Sep 30, 2025 | 9.99% |
| Jun 30, 2025 | 9.10% |
| Mar 31, 2025 | 5.75% |
| Dec 31, 2024 | 6.85% |
| Sep 30, 2024 | 22.69% |
| Jun 30, 2024 | 12.13% |
| Mar 31, 2024 | 12.39% |
| Dec 31, 2023 | 34.17% |
| Sep 30, 2023 | 3.82% |
| Jun 30, 2023 | 15.05% |
| Mar 31, 2023 | 11.51% |
| Jun 30, 2021 | -0.25% |
| Mar 31, 2021 | 0.27% |
| Dec 31, 2020 | -0.50% |
| Sep 30, 2020 | -0.81% |
| Jun 30, 2020 | -2.88% |
| Mar 31, 2020 | -1.74% |